
|Articles|April 16, 2007
Latebreakers: Combo diabetes drug gets FDA nod
The FDA has approved the combination of sitagliptin (Januvia, Merck) and metformin for the treatment of Type 2 diabetes.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Embedded Pharmacists Are Vital Yet Underutilized in Diabetes Care
2
The Prodigious PBM Pivot: How Supply Chain Entities Will Move Forward After CAA 2026
3
Executive Order Calls for Realignment of Childhood Vaccines
4
Pneumococcal Vaccination at 50 Years Old Can Improve Outcomes
5





























































